ClinicalTrials.Veeva

Menu

Pilot Text Message for Influenza Vaccination

Columbia University logo

Columbia University

Status

Completed

Conditions

Influenza

Treatments

Behavioral: text message

Study type

Interventional

Funder types

Other

Identifiers

NCT01761734
AAAK5058

Details and patient eligibility

About

Influenza is an important and potentially preventable cause of morbidity and mortality, yet only 46% of U.S. adults were vaccinated by the end of the 2011-12 influenza season despite influenza vaccination being widely recommended, effective, and safe. Influenza vaccination rates are even lower in racial/ethnic minority groups. In order to address the problem of low influenza vaccination rates in minority adults, we plan to build on the well-accepted practice of immunization recall-reminders and the emerging practice of using text message to pilot the feasibility of using text messaging to improve influenza vaccination coverage rates in a low health literacy, largely minority, publicly insured adult population.

Enrollment

1,000 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > or = 18 years of age,
  • at least one visit to the AIM clinic during the previous year
  • a cell phone number in the registration system
  • fluent in English or Spanish. Exclusion criteria

Exclusion criteria

  • Receipt of influenza vaccination during the 2012-2013 influenza season prior to randomization.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,000 participants in 2 patient groups

text message
Experimental group
Description:
receipt of text message
Treatment:
Behavioral: text message
usual care
No Intervention group
Description:
usual care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems